Stock market Updates | Procter & Gamble Health Ltd. | R Wadiwala Securities Pvt Ltd
NIFTY15039.30  +120.20 (+0.81%)
SENSEX50702.55  +405.66 (+0.81%)
  • top gainers
  • top losers
  • top volume
  • top value
investments Associate Login Online Trading Login
  • indian indices
  • global indices

We are investment service provider for Buy stocks , Low Stocks Brokerage , Stocks Portfolio Management in Surat , NRI Investment in Stocks , Share Broking Surat , Stock Broking Surat , Advisory Services Surat and Competetive Stocks Brokerage. investment advisory, financial integrity and prompt services in the whole of South Gujarat.

L
equity
Home Markets & NewsCompany ProfileSmart Quotes

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC
BSE6792.3523.55 (+0.35 %)
PREV CLOSE (Rs.) 6768.80
OPEN PRICE (Rs.) 6828.65
BID PRICE (QTY) 6777.55 (2)
OFFER PRICE (QTY) 6792.35 (3)
VOLUME 185
TODAY'S LOW / HIGH (Rs.)6746.80 6838.30
52 WK LOW / HIGH (Rs.)2927.8 7499.95
NSE6790.0013.7 (+0.2 %)
PREV CLOSE( Rs. ) 6776.30
OPEN PRICE (Rs.) 6780.00
BID PRICE (QTY) 6786.00 (1)
OFFER PRICE (QTY) 6790.10 (3)
VOLUME 1391
TODAY'S LOW / HIGH(Rs.) 6757.95 6843.40
52 WK LOW / HIGH (Rs.)2891.45 7500

Smart Quotes

BSE NSE
1D 1M 3M 1Y 3Y 5Y
Stock Summary
Trade Value (Rs. in Lacs)
12.57
Dividend Yield(%)
3.38
TTM EPS (Rs.)
134.02
P/E Ratio
50.79
Book Value (Rs.)
580.54
Face Value (Rs.)
10
MCap (Rs. in Mn)
112991.99
Price/Earning (TTM)
45.20
Price/Sales (TTM)
12.10
Price/Book (MRQ)
11.73
PAT Margin (%)
18.74
ROCE (%)
29.01
company info
Incorporation Year : 26-04 1967

Management Info :

Suresh N Talwar - Chairman Milind Thatte - Managing Director

Registered Office :

Address : Godrej One, 8th Floor,Pirojshanagar,Eastern Express Highway, Vikhroli (East),
Mumbai,
Maharashtra-400079

Phone : 022 6866 9000

Registrars Details :

K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
News
08Jan Board Meeting Intimation for Consider
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Boar..
28Nov Procter & Gamble Health informs about
Procter & Gamble Health has informed that the 53rd Annual General Me..
20Mar Procter & Gamble Health informs about
Procter & Gamble Health has informed about the loss/ misplacement of..
more
Financials
QTR Dec 20 ANNUAL 19
Net Profit678.81587.58
Gross Profit 864.3 2343.59
Operating Profit 944.7 2515.24
Net Sales 2402.2 9265.98
more
Rs. in Millions
Rolling Forward P/E (EOD)
Event Calendar
peer group
Abbott India (BSE)
Rwadiwala-peer-arrow  14586.80 (0.44%)
M.Cap (Rs. in Cr)31011.55
Astrazeneca Pharma I (BSE)
Rwadiwala-peer-arrow  3530.00 (1.71%)
M.Cap (Rs. in Cr)8776.25
Hester Biosciences (BSE)
Rwadiwala-peer-arrow  1789.65 (3.00%)
M.Cap (Rs. in Cr)1497.93
Piramal Enterprises (BSE)
Rwadiwala-peer-arrow  1968.60 (2.64%)
M.Cap (Rs. in Cr)43979.97
Shareholding Pattern
MUTUAL FUNDS/UTI
6.34%
PROMOTERS
51.82%
FI/BANKS/INSURANCE
5.38%
NON-INSTITUTION
30.31%
GOVERNMENT
0%
FII
0%
more
Mf Holdings
ATTENTION INVESTORS|KYC|IPO|PROPRIETARY TRADING
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors.    
CORPORATE OFFICE
address
  • 9/2003-4,
  • Vishnu Priya Limda Chowk
  • Main Road
  • Surat – 395 003.
fax us @ +91-261-6673537
email us @ info@rwadiwala.com

Feed Back  | Terms & Conditions  | SEBI  | FMC  | NSE  | BSE  | MCX  | NCDEX  | IRDA  |  AMFI  | Disclaimer  | Privacy Policy  | Careers | User Agreements  | Ethics Policy  | Investor Protection  |  Dos and Don'ts   |  Rights and Obligations   |  Uniform Risk Disclosure   |   Important Policies   |  To File A Complaint on SCORES   | Sitemap 

SEBI Regn No. BSE - CM/F&O, NSE - CM/F&O/CDS: INZ000187332 | SEBI PMS regn no.: INP000004045 | MCX & NCDEX SEBI Regn No.: INZ000080636 | CDSL DP ID: 12043100
| R Wadiwala Securities Pvt Ltd - CIN: U67120GJ2004PTC044324 | R Wadiwala Commodities Pvt Ltd - CIN: U51109GJ2007PTC050176

Compliance Officer - Email ID: compliance@rwadiwala.com | Contact No.: 0261-6673542

The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by us, our employees, and our servants.

Investor Greivance Redressal at support@rwadiwala.com

Copyright © 2016 | All Rights Reserved. R.Wadiwala group.

Designed & Developed by ●●● Accord Fintech Pvt. Ltd.